(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 3.59% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.
Amedisys's revenue in 2025 is $2,371,691,000.On average, 7 Wall Street analysts forecast AMED's revenue for 2025 to be $80,635,717,290, with the lowest AMED revenue forecast at $79,716,275,131, and the highest AMED revenue forecast at $82,265,704,611.
In 2026, AMED is forecast to generate $84,666,329,852 in revenue, with the lowest revenue forecast at $82,705,487,760 and the highest revenue forecast at $87,451,207,415.